HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired Pten expression in human malignant peripheral nerve sheath tumours.

Abstract
Malignant peripheral nerve sheath tumours (MPNST) are aggressive sarcomas that develop in about 10% of patients with the genetic disease neurofibromatosis type 1 (NF1). Molecular alterations contributing to MPNST formation have only partially been resolved. Here we examined the role of Pten, a key regulator of the Pi3k/Akt/mTOR pathway, in human MPNST and benign neurofibromas. Immunohistochemistry showed that Pten expression was significantly lower in MPNST (n=16) than in neurofibromas (n=16) and normal nervous tissue. To elucidate potential mechanisms for Pten down-regulation or Akt/mTOR activation in MPNST we performed further experiments. Mutation analysis revealed absence of somatic mutations in PTEN (n=31) and PIK3CA (n=38). However, we found frequent PTEN promotor methylation in primary MPNST (11/26) and MPNST cell lines (7/8) but not in benign nerve sheath tumours. PTEN methylation was significantly associated with early metastasis. Moreover, we detected an inverse correlation of Pten-regulating miR-21 and Pten protein levels in MPNST cell lines. The examination of NF1-/- and NF1+/+Schwann cells and fibroblasts showed that Pten expression is not regulated by NF1. To determine the significance of Pten status for treatment with the mTOR inhibitor rapamycin we treated 5 MPNST cell lines with rapamycin. All cell lines were sensitive to rapamycin without a significant correlation to Pten levels. When rapamycin was combined with simvastatin a synergistic anti-proliferative effect was achieved. Taken together we show frequent loss/reduction of Pten expression in MPNST and provide evidence for the involvement of multiple Pten regulating mechanisms.
AuthorsMaren Bradtmöller, Christian Hartmann, Jan Zietsch, Sebastian Jäschke, Victor-F Mautner, Andreas Kurtz, Su-Jin Park, Michael Baier, Anja Harder, David Reuss, Andreas von Deimling, Frank L Heppner, Nikola Holtkamp
JournalPloS one (PLoS One) Vol. 7 Issue 11 Pg. e47595 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID23139750 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neurofibromin 1
  • Simvastatin
  • Ribosomal Protein S6 Kinases, 70-kDa
  • PTEN Phosphohydrolase
  • PTEN protein, human
  • Sirolimus
Topics
  • Animals
  • Blotting, Western
  • Cell Line, Tumor
  • Drug Synergism
  • Fibroblasts (drug effects, metabolism, pathology)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Mice
  • Nerve Sheath Neoplasms (enzymology, genetics, pathology)
  • Neurofibroma (enzymology, genetics, pathology)
  • Neurofibromin 1 (metabolism)
  • PTEN Phosphohydrolase (genetics, metabolism)
  • Ribosomal Protein S6 Kinases, 70-kDa (metabolism)
  • Simvastatin (pharmacology)
  • Sirolimus (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: